Deal Library / Pharma BD Deal Intelligence

Mallinckrodt plc — Pharma Deals

The Pharma Closeout tracks 6 deals, $12.2B in disclosed deal value, 6 with a post-close Outcome Score for Mallinckrodt plc.

Median Critic Score: 54 · Median Outcome Score: 28

All 6 deals

Mallinckrodt plc / Cadence Pharmaceuticals, Inc. — 2014 · $1.4B · Mixed — partial payoff, real shortfalls.
Mallinckrodt plc / Therakos, Inc. — 2015 · $1.3B · Mixed — partial payoff, real shortfalls.
Mallinckrodt plc / Ikaria, Inc. — 2015 · $2.3B · Underwhelmed — fell short of the thesis.
Mallinckrodt plc / Sucampo Pharmaceuticals, Inc. — 2017 · $1.2B · Did not work — the deal failed to deliver.
Mallinckrodt plc / Questcor Pharmaceuticals, Inc. — 2014 · $5.6B · Did not work — the deal failed to deliver.
Mallinckrodt plc / InfaCare Pharmaceutical Corporation — 2017 · $425M · Did not work — the deal failed to deliver.